A Focus Group Study of Self-Management in Patients With Glomerular Disease

Simon A Carter^{1

2}, Claris Teng², Talia Gutman^{1

2}, Charlotte Logeman², Dan Cattran^{3

4}, Liz Lightstone⁵, Arvind Bagga⁶, Sean J Barbour⁷, Jonathan Barratt^{8

9}, John Boletis¹⁰, Dawn J Caster¹¹, Rosanna Coppo¹², Fernando C Fervenza¹³, Jürgen Floege¹⁴, Michelle A Hladunewich^{3

15}, Jonathan J Hogan¹⁶, A Richard Kitching^{17

18}, Richard A Lafayette^{19

20}, Ana Malvar²¹, Jai Radhakrishnan²², Brad H Rovin²³, Nicole Scholes-Robertson^{1

2}, Hernán Trimarchi²⁴, Hong Zhang²⁵, Karolis Azukaitis²⁶, Yeoungjee Cho^{27

28

29}, Andrea K Viecelli^{27

28}, Louese Dunn³⁰, David Harris^{31

32}, David W Johnson^{27

28

29}, Peter G Kerr¹⁸, Paul Laboi³³, Jessica Ryan^{17

18}, Jenny I Shen³⁴, Lorena Ruiz³⁴, Angela Yee-Moon Wang³⁵, Achilles Hoi Kan Lee³⁶, Samuel Fung Ka Shun³⁷, Matthew Ka-Hang Tong³⁸, Armando Teixeira-Pinto^{1

2}, Martin Wilkie³⁹, Stephen I Alexander², Jonathan C Craig⁴⁰, Adam Martin², Allison Tong^{1

2}

Affiliations

¹ Sydney School of Public Health, The University of Sydney, Sydney, Australia.
² Centre for Kidney Research, The Children's Hospital at Westmead, Sydney, Australia.
³ Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
⁴ Toronto General Research Institute, Toronto, Ontario, Canada.
⁵ Centre for Inflammatory Disease, Faculty of Medicine, Imperial College London, London, UK.
⁶ Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
⁷ Division of Nephrology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
⁸ Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.
⁹ John Walls Renal Unit, Leicester General Hospital, Leicester, UK.
¹⁰ Nephrology Department and Renal Transplantation Unit, Medical School, University of Athens, Laiko Hospital, Athens, Greece.
¹¹ Division of Nephrology, University of Louisville, Louisville, Kentucky, USA.
¹² Fondazione Ricerca Molinette, Regina Margherita Hospital, Turin, Italy.
¹³ Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
¹⁴ Department of Nephrology and Clinical Immunology, RWTH University Hospital, Aachen, Germany.
¹⁵ Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
¹⁶ Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
¹⁷ Department of Nephrology, Monash Health, Victoria, Australia.
¹⁸ Centre for Inflammatory Diseases, Monash University Department of Medicine, Victoria, Australia.
¹⁹ Stanford University Medical Center, Stanford, California, USA.
²⁰ Department of Medicine, Division of Nephrology, Stanford University, Stanford, California, USA.
²¹ Nephrology, Hospital Fernández, Buenos Aires, Argentina.
²² Columbia University Irving Medical Center, New York, New York, USA.
²³ Department of Internal Medicine, Division of Nephrology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
²⁴ Nephrology Service and Kidney Transplantation Unit, Hospital Britanico de Buenos Aires, Buenos Aires, Argentina.
²⁵ Renal Division, Peking University First Hospital, Beijing, People's Republic of China.
²⁶ Clinic of Pediatrics, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
²⁷ Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.
²⁸ Australasian Kidney Trials Network, University of Queensland, Brisbane, Australia.
²⁹ Translational Research Institute, Brisbane, Australia.
³⁰ Sheffield Kidney Institute, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
³¹ Westmead Institute for Medical Research, The University of Sydney, Sydney, Australia.
³² Sydney Medical School, The University of Sydney, Sydney, Australia.
³³ Department of Nephrology, York Hospital, York, UK.
³⁴ Division of Nephrology and Hypertension, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, USA.
³⁵ Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pok Fu Lam, Hong Kong SAR, China.
³⁶ Department of Medicine, Tuen Mun Hospital, Tuen Mun, Hong Kong SAR, China.
³⁷ Department of Medicine and Geriatrics, Princess Margaret Hospital, Kowloon, Hong Kong SAR, China.
³⁸ Department of Medicine and Geriatrics, Pok Oi Hospital, Au Tau, Hong Kong SAR, China.
³⁹ Department of Nephrology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
⁴⁰ College of Medicine and Public Health, Flinders University, Adelaide, Australia.

PMID: 35005314
PMCID: PMC8720796
DOI: 10.1016/j.ekir.2021.10.011

A Focus Group Study of Self-Management in Patients With Glomerular Disease

Simon A Carter et al. Kidney Int Rep. 2021.

. 2021 Oct 30;7(1):56-67.

doi: 10.1016/j.ekir.2021.10.011. eCollection 2022 Jan.

Authors

Affiliations

¹ Sydney School of Public Health, The University of Sydney, Sydney, Australia.
² Centre for Kidney Research, The Children's Hospital at Westmead, Sydney, Australia.
³ Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
⁴ Toronto General Research Institute, Toronto, Ontario, Canada.
⁵ Centre for Inflammatory Disease, Faculty of Medicine, Imperial College London, London, UK.
⁶ Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
⁷ Division of Nephrology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
⁸ Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.
⁹ John Walls Renal Unit, Leicester General Hospital, Leicester, UK.
¹⁰ Nephrology Department and Renal Transplantation Unit, Medical School, University of Athens, Laiko Hospital, Athens, Greece.
¹¹ Division of Nephrology, University of Louisville, Louisville, Kentucky, USA.
¹² Fondazione Ricerca Molinette, Regina Margherita Hospital, Turin, Italy.
¹³ Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
¹⁴ Department of Nephrology and Clinical Immunology, RWTH University Hospital, Aachen, Germany.
¹⁵ Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
¹⁶ Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
¹⁷ Department of Nephrology, Monash Health, Victoria, Australia.
¹⁸ Centre for Inflammatory Diseases, Monash University Department of Medicine, Victoria, Australia.
¹⁹ Stanford University Medical Center, Stanford, California, USA.
²⁰ Department of Medicine, Division of Nephrology, Stanford University, Stanford, California, USA.
²¹ Nephrology, Hospital Fernández, Buenos Aires, Argentina.
²² Columbia University Irving Medical Center, New York, New York, USA.
²³ Department of Internal Medicine, Division of Nephrology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
²⁴ Nephrology Service and Kidney Transplantation Unit, Hospital Britanico de Buenos Aires, Buenos Aires, Argentina.
²⁵ Renal Division, Peking University First Hospital, Beijing, People's Republic of China.
²⁶ Clinic of Pediatrics, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
²⁷ Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.
²⁸ Australasian Kidney Trials Network, University of Queensland, Brisbane, Australia.
²⁹ Translational Research Institute, Brisbane, Australia.
³⁰ Sheffield Kidney Institute, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
³¹ Westmead Institute for Medical Research, The University of Sydney, Sydney, Australia.
³² Sydney Medical School, The University of Sydney, Sydney, Australia.
³³ Department of Nephrology, York Hospital, York, UK.
³⁴ Division of Nephrology and Hypertension, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, USA.
³⁵ Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pok Fu Lam, Hong Kong SAR, China.
³⁶ Department of Medicine, Tuen Mun Hospital, Tuen Mun, Hong Kong SAR, China.
³⁷ Department of Medicine and Geriatrics, Princess Margaret Hospital, Kowloon, Hong Kong SAR, China.
³⁸ Department of Medicine and Geriatrics, Pok Oi Hospital, Au Tau, Hong Kong SAR, China.
³⁹ Department of Nephrology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
⁴⁰ College of Medicine and Public Health, Flinders University, Adelaide, Australia.

PMID: 35005314
PMCID: PMC8720796
DOI: 10.1016/j.ekir.2021.10.011

Abstract

Introduction: Patients with glomerular disease experience symptoms that impair their physical and mental health while managing their treatments, diet, appointments and monitoring general and specific indicators of health and their illness. We sought to describe the perspectives of patients and their care partners on self-management in glomerular disease.

Methods: We conducted 16 focus groups involving adult patients with glomerular disease (n = 101) and their care partners (n = 34) in Australia, Hong Kong, the United Kingdom, and United States. Transcripts were analyzed thematically.

Results: We identified the following 4 themes: empowered in autonomy (gaining confidence through understanding, taking ownership of disease and treatment, learning a positive health approach); overwhelmed by compounding treatment burdens (financially undermined and depleted, demoralized by side effects and harms, frustrated by fragmented and inflexible care, fear of possible drug harms); striving for stability and normalcy (making personal sacrifices, maximizing life participation, attentiveness to bodily signs, avoiding precarious health states, integrating medicines into routines); and necessity of health-sustaining relationships (buoyed by social support, fulfilling meaningful responsibilities, sharing and normalizing experiences, seeking a trusting and respectful alliance).

Conclusion: Patients with glomerular disease and their care partners value their capacity for autonomy and disease ownership, stability of their health, and relationships that support self-management. Strategies directed at strengthening these factors may increase self-efficacy and improve the care and outcomes for patients with glomerular disease.

Keywords: focus groups; glomerulonephritis; personal autonomy; self-management; therapeutic alliance.

PubMed Disclaimer

Figures

**Figure 1**
Thematic schema relating the motivators, barriers, and attitudes to self-management in patients with glomerular disease.

See this image and copyright information in PMC

References

1. Herlyn K., Hellmich B., Seo P., Merkel P.A. Patient-reported outcome assessment in vasculitis may provide important data and a unique perspective. Arthritis Care Res (Hoboken) 2010;62:1639–1645. doi: 10.1002/acr.20276. - DOI - PMC - PubMed
1. Daleboudt G.M., Berger S.P., Broadbent E., Kaptein A.A. Health-related quality of life in patients with systemic lupus erythematosus and proliferative lupus nephritis. Psychol Health Med. 2011;16:393–404. doi: 10.1080/13548506.2011.554566. - DOI - PubMed
1. Canetta P.A., Troost J.P., Mahoney S., et al. Health-related quality of life in glomerular disease. Kidney Int. 2019;95:1209–1224. doi: 10.1016/j.kint.2018.12.018. - DOI - PMC - PubMed
1. Lee H., Kim D.K., Oh K.H., et al. Mortality and renal outcome of primary glomerulonephritis in Korea: observation in 1,943 biopsied cases. Am J Nephrol. 2013;37:74–83. doi: 10.1159/000345960. - DOI - PubMed
1. Yap D.Y., Tang C.S., Ma M.K., Lam M.F., Chan T.M. Survival analysis and causes of mortality in patients with lupus nephritis. Nephrol Dial Transplant. 2012;27:3248–3254. doi: 10.1093/ndt/gfs073. - DOI - PubMed

Grants and funding

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

A Focus Group Study of Self-Management in Patients With Glomerular Disease

Affiliations

A Focus Group Study of Self-Management in Patients With Glomerular Disease

Authors

Affiliations

Abstract

Figures

References

Grants and funding

LinkOut - more resources

Full Text Sources